vcfirmsdirectory.com

SEC exempt reporting adviser · Early stage

NTI

NeuroTechnology Investors is a physician-run investor network that backs emerging medtech companies, mainly in neuro and vascular fields, combining capital with clinical expertise through a non-fund investment vehicle.

Mountain ViewRegistered · Mountain View
New investments · 12 months
Fund vehiclesPublic
9
9 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:09 CETSources: themdadvantage.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round NTI joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is NTI right for your round?

Is NTI a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
9
9 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

NEUROTECHNOLOGY PARTNERS FUND, LLCUS private fund · Active · United States · $12.2M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS II, LLCUS private fund · Active · United States · $11.6M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS VI, LLCUS private fund · Active · United States · $8.7M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS V, LLCUS private fund · Active · United States · $7.5M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS III, LLCUS private fund · Active · United States · $5.8M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS, LLCUS private fund · Active · United States · $4.3M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS IV, LLCUS private fund · Active · United States · $4.2M gross assets · filed 7 Mar 2026
NEUROTECHNOLOGY INVESTORS VII, LLCUS private fund · Active · United States · $1.9M gross assets · filed 7 Mar 2026
NTI STROKE DIAGNOSTICS, LLCUS private fund · Active · United States · $296 gross assets · filed 7 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds NTI joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round NTI joined

Round sizes, NTI’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

SynchronRadical Catheter TechnologiesSerenity MedicalNeuroradial Technologies, Inc.Basecamp VascularBlink CNSBorvo MedicalEndoStream

Portfolio and exits

Every company NTI backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where NTI puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet NTI

Events where NTI’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet NTI’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

7 Mar 2026Fund filingForm ADV filed by NTI MANAGERS, LLC: 9 private funds, $56.2M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

NTI is based in Mountain View, United States.

9 fund vehicles are on public registers (SEC adviser filings), including NEUROTECHNOLOGY PARTNERS FUND, LLC, NEUROTECHNOLOGY INVESTORS II, LLC and NEUROTECHNOLOGY INVESTORS VI, LLC.

Stages: Seed, Series A. Sectors: Medtech. From the firm’s own website.

Physicians are especially well placed to judge emerging medical technologies but are often sidelined by large financial institutions that invest later. The network invests as a bloc to negotiate better terms and contributes clinical expertise alongside capital to speed patient access to clinical solutions. From the firm’s own website.

NTI lists 8 portfolio companies on its website, including Synchron, Radical Catheter Technologies, Serenity Medical, Neuroradial Technologies, Inc. and Basecamp Vascular.

Firms whose websites list some of the same companies include ARCH Venture Partners, Armyn Capital and Axial Partners.

Know before NTI’s next round is announced.

PRO tracks NTI’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

NTIGet NTI’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.